Agilent Acquires MassCode IP for Multiplex PCR, Plans to Commercialize Infectious Disease Panels
December 03, 2009
Agilent Acquires MassCode IP for Multiplex PCR, Plans to Commercialize Infectious Disease Panels
The company is currently collaborating with Ian Lipkin's lab at Columbia University to co-develop a set of MassTag PCR panels for infectious disease screening that it plans to commercialize some time in the next year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Abbott, GenLab Developing Molecular Assay for Orthopedic Infections
March 5, 2012 / GenomeWeb Daily News - Agilent Q1 Revenues Rise 8 Percent as Life Sciences Bounce 14 Percent
February 15, 2012 / GenomeWeb Daily News - Revising Molecular Dx Roadmap, Qiagen Will Migrate PCR Tests Across Automated Platforms
May 12, 2011 / PCR Insider - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 5, 2011 / PCR Insider - Meridian Bioscience Q1 Revs Drop 12 Percent
January 20, 2011 / GenomeWeb Daily News